These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 5146426

  • 1. Reserpine therapy of phenothiazine induced dyskinesia.
    Sato S, Daly R, Peters H.
    Dis Nerv Syst; 1971 Oct; 32(10):680-5. PubMed ID: 5146426
    [No Abstract] [Full Text] [Related]

  • 2. Reserpine: cause and treatment of oral-facial dyskinesia.
    Wolf SM.
    Bull Los Angeles Neurol Soc; 1973 Apr; 38(2):80-4. PubMed ID: 4702802
    [No Abstract] [Full Text] [Related]

  • 3. Persistent dyskinesia.
    Crane GE.
    Br J Psychiatry; 1973 Apr; 122(569):395-405. PubMed ID: 4577946
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of phenothiazine-induced dyskinesia.
    Goldman D.
    Psychopharmacol Bull; 1976 Apr; 12(2):7, 10. PubMed ID: 3820
    [No Abstract] [Full Text] [Related]

  • 5. The dyskenesias: a new therapeutic approach.
    Bucci L.
    Dis Nerv Syst; 1971 May; 32(5):324-7. PubMed ID: 4931496
    [No Abstract] [Full Text] [Related]

  • 6. Mediocre effects of reserpine on tardive dyskinesia.
    Crane GE.
    N Engl J Med; 1973 Jan 11; 288(2):104-5. PubMed ID: 4681968
    [No Abstract] [Full Text] [Related]

  • 7. Reserpine for tardive dyskinesia.
    Peters HA, Daly RF, Sato S.
    N Engl J Med; 1972 Jan 13; 286(2):106. PubMed ID: 5006867
    [No Abstract] [Full Text] [Related]

  • 8. [Attempt at treatment of permanent type of post-neuroleptic dyskinesia].
    Villeneuve A, Böszörményi Z, Deschambault M, Lachance R.
    Laval Med; 1970 Sep 13; 41(7):923-33. PubMed ID: 5509490
    [No Abstract] [Full Text] [Related]

  • 9. Reserpine for tardive dyskinesia.
    Duvoisin RC.
    N Engl J Med; 1972 Mar 16; 286(11):611. PubMed ID: 5058810
    [No Abstract] [Full Text] [Related]

  • 10. [Possibilities of target therapy; combined reserpine-phenothiazine therapy of schizophrenia].
    NEUMANN H.
    Nervenarzt; 1959 Jun 20; 30(6):252-6. PubMed ID: 13674499
    [No Abstract] [Full Text] [Related]

  • 11. "Permanent" or complex dyskinesias in the aged.
    Paulson GW.
    Geriatrics; 1968 Sep 20; 23(9):105-10. PubMed ID: 5673659
    [No Abstract] [Full Text] [Related]

  • 12. Effects of short-term reserpine treatment on generalized and focal dystonic-dyskinetic syndromes.
    Raffaele R, Patti F, Sciacca A, Palmeri A.
    Funct Neurol; 1988 Sep 20; 3(3):327-35. PubMed ID: 3192107
    [Abstract] [Full Text] [Related]

  • 13. Shortlasting akathisia during combined electroconvulsive and phenothiazine therapy.
    Lutz EG.
    Dis Nerv Syst; 1968 Apr 20; 29(4):259-60. PubMed ID: 5652491
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Apparently irreversible dyskinesia syndrome following prolonged use of phenothiazine drugs].
    Lafora GR.
    Arch Neurobiol (Madr); 1968 Apr 20; 31(1):3-20. PubMed ID: 5739860
    [No Abstract] [Full Text] [Related]

  • 17. Persistent phenothiazine dyskinesia treated with tetrabenazine.
    Godwin-Austen RB, Clark T.
    Br Med J; 1971 Oct 02; 4(5778):25-6. PubMed ID: 4938245
    [Abstract] [Full Text] [Related]

  • 18. Treatment of phenothiazine-induced dyskinesia.
    Goldman D.
    Psychopharmacology (Berl); 1976 Jun 23; 47(3):271-2. PubMed ID: 9653
    [Abstract] [Full Text] [Related]

  • 19. Drug induced dyskinesia: reality or myth?
    Turek IS.
    Dis Nerv Syst; 1975 Jul 23; 36(7):397-9. PubMed ID: 807464
    [Abstract] [Full Text] [Related]

  • 20. Treatment with hemiballism with reserpine.
    Obeso JA, Marti-Masso JF, Astudillo W, de la Puente E, Carrera N.
    Ann Neurol; 1978 Dec 23; 4(6):581. PubMed ID: 742863
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.